Skip to main content
. 2023 Jun 16;14:1190883. doi: 10.3389/fimmu.2023.1190883

Figure 2.

Figure 2

CTA-based immunotherapy has recently been used in cancer treatment and achieved promising outcomes. It mainly includes oncolytic virus therapies, cancer vaccines, adoptive cell transfer, and immune checkpoint inhibitors.